Poland· PL-100218262

Nebilet HCT

A nebivolol und thiazide product containing nebivololum + hydrochlorothiazidum, registered in Poland by Menarini International Operations Luxembourg S.A.. The same ATC class is registered in 9 of our 19 countries.

ATC C07BB12

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedNebilet HCTATCC07BB12REGISTER NO.PL-100218262PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Nebivolol und thiazide is registered in 9 of 19 countries.

Countries holding a registration under ATC C07BB12 (nebivolol und thiazide), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Nebivolol und thiazide · ATC C07BB12

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Nebivololum + Hydrochlorothiazidum
Manufacturer
Menarini International Operations Luxembourg S.A.
Country
Poland (PL)
ATC code
C07BB12
ATC class
Nebivolol und Thiazide
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909990740642
  • gtin
    05909990740659
  • gtin
    05909990740666

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Nebivolol und thiazide in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nebivolol und thiazide products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Nomexor Plus Hct
  • Belgium · Nebivolol/Hct Eg, Nobiretic
  • Bulgaria · Кардиостад Плюс, Небилет Плюс
  • Cyprus · Lobivon-Plus
  • Czechia · Nebilet Plus H
  • Germany · Nebivolol Comp. Abz, Nebivolol Comp. Ratiopharm
  • Denmark · Hypoloc Comp
  • Estonia · Nebilet Plus
  • Spain · Lobivon Plus, Silostar Plus
  • Finland · Hypoloc Comp
  • France · Conebilox, Nebivolol/Hydrochlorothiazide Biogaran
  • Greece · Hypoloc-Plus, Lobivon-Plus
  • Croatia · Nebilet Plus
  • Hungary · Nebilet Plus
  • Ireland · Nebilet Plus
  • Italy · Aloneb, Lobidiur
  • Lithuania · Nebilet Plus
  • Luxembourg · Nobiretic
  • Latvia · Nebilet Plus
  • Malta · Nebilet Plus
  • Netherlands · Hyporetic, Lobiretic
  • Portugal · Nebilet Hct
  • Romania · Co-Nebilet
  • Slovenia · Co-Nebilet
  • Slovakia · Nebilet Hctz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a24611ef-34d1-49a1-8722-e34e99730a32
GET /v1/drugs/a24611ef-34d1-49a1-8722-e34e99730a32?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "5 mg + 12,5 mg",
  "packaging": "05909990740642 ¦ Rp ¦ 54124\n7 tabl.\n05909990740659 ¦ Rp ¦ 54125\n14 tabl.\n05909990740666 ¦ Rp ¦ 54126\n28 tabl.",
  "substance": "Nebivololi hydrochloridum 5.45 mg + Hydrochlorothiazidum 12.5 mg",
  "common_name": "Nebivololum + Hydrochlorothiazidum",
  "pl_product_id": "100218262",
  "pozwolenie_nr": "16084",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about nebivolol und thiazide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.